Global Healing Vision

Dr. Schimpff is the retired Chief Executive Officer of the University Medical Center.

Dr. Schimpff, an Eagle Scout, is a 1963 graduate of Rutgers University where he was a Henry Rutgers Scholar. He was also recipient of the Van Der Poole Award for Excellence in Medicinal Chemistry. He obtained his M.D. degree in 1967 at Yale Medical School and was inducted into Alpha Omega Alpha, the national medical honor society. His internal medicine internship and residency was at Yale-New Haven Hospital (1967-1969).

He was a Clinical Associate in the Baltimore Cancer Research Center (BCRC) of the National Cancer Institute from 1969-1972. He was a Fellow in the National Institute of Allergy and Infectious Diseases, NIH, from 1972-1973. He is Board certified in Internal Medicine, Medical Oncology and Infectious Diseases.

Dr. Schimpff was Senior Investigator in the National Cancer Institute’s BCRC from 1973 to1976. In 1976 he became Head, Section of Infectious Diseases and Microbiology at the BCRC and from 1979 was, concurrently, Head, Division of Infectious Diseases, Department of Medicine, at the University of Maryland School of Medicine.

He became internationally recognized for his research into the causes, prevention and treatment of infection in cancer patients undergoing aggressive cancer therapy. He has published over 200 scientific articles, reviews and book chapters and has edited three text books, including “Comprehensive Textbook of Oncology.” Clinically he devoted most of his time to treating patients with acute leukemia and lymphomas.

He was promoted to professor of medicine in the School of Medicine in 1979 and granted tenure in 1982. He was also appointed as professor of pharmacology and professor of oncology in 1982.

In 1982, he was appointed founding Director of the University of Maryland Cancer Center. In 1985, he became Executive Vice President and Chief Operating Officer of the newly created University of Maryland Medical System in Baltimore.

Dr. Schimpff became Chief Executive Officer of the Medical System’ s flagship, the University of Maryland Medical Center, in 1999.  The Medical Center admits about 30,000 patients per year, largely for tertiary care, and includes the world’s preeminent trauma center and the country’s largest kidney transplant program. There are about 5000 staff with a budget of $750million; all medical care is provided by faculty of the School of Medicine.

Since retirement in 2004, Dr. Schimpff has written a book for a general audience entitled “The Future of Medicine: Megatrends in Healthcare That Will Affect Your Quality of Life.” It is focused on genomics, vaccines, technology, imaging, stem cells, the operating room and information management. It was published by Thomas Nelson Books over the summer of 2007.

He is deeply committed to advancing patient safety and has served as a consultant to the United States Army on mechanisms to interdigitate high technology into improved patient safety in the “operating room of the future.” He has been consultant to the Battelle Memorial Institute in techniques to assist states or institutions to augment translational research activities. Dr Schimpff is a board member of two medical technology companies, CytoPulse Sciences, Inc and Salar Inc.

He is a Professor of Medicine at the University of Maryland School of Medicine where he teaches residents and fellows in oncology and infectious diseases and he is a Research Professor of Public Policy at the University of Maryland College Park. He was the lead on a proposal to the Department of Homeland Security to build and operate a 500,000 sf biocontainment research institution to be known as the National Bio-Agro Defense Facility designed to study foreign biothreats to the country’s food supply.

Dr. Schimpff belongs to many societies and professional organizations including the EORTC’s International Anti-microbial Therapy Project Group of which he is a co-founder and the Multinational Association of Supportive Care in Cancer of which he is also a cofounder. He is a fellow of the American College of Physicians, a member of the American Society of Clinical Oncology, Infectious Diseases Society of America, the American Association of Cancer Research and has been active in the University Health System Consortium and the Association of American Medical Colleges.  He was Treasurer of the American Society of Clinical Oncology from 1985 – 1989 and was a member of the National Board of Medical Examiners for six years.

Dr. Schimpff was chair of the Board of Governors of the National Institutes of Health’s Warren G. Magnuson Clinical Center from January 1999 until 2003; he was a board member since its inception in 1996 and member of the Board’s Executive Committee and chair of the Finance Working Group. 

Civic activities have included the Downtown Partnership of Baltimore, Inc. Board of Directors and the March of Dimes, Maryland Chapter, Board of Directors.  He was a member for ten years of the University of Maryland School of Pharmacy Board of Visitors.  Dr. Schimpff served as a member of the boards of the Maryland Hospital Education Institute; the American Cancer Society, Maryland Division (President from 1990-1992); Maryland Association of Nonprofit Organizations (Chairman, Board of Directors from 1994-1997); the Maryland Hospital Association Board of Directors (1998- 2003); the Easter Seals Society of Maryland (Vice Chairman 1991-1992) and with his wife was co-leader of a Girl Scout Troop.

Dr Schimpff has been married to Carol Rawstrom Schimpff for 44 years. Mrs. Schimpff is a retired architect and commercial real estate pension advisor; she now docents at the Walters Art Museum. Their daughter, Elizabeth, is a CFA and former vice president of credit analysis at Merrill Lynch’s Tokyo office; she and her family have recently moved from Tokyo to Los Angeles.

For more information, please visit: www.medicalmegatrends.com.